May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Application of Thermo-setting Gel as Artificial Vitreous
Author Affiliations & Notes
  • Y. Katagiri
    Ophthalmology, Tokyo medical University Hospital, Shinjuku, Japan
  • T. Iwasaki
    Ophthalmology, Tokyo medical University Hospital, Shinjuku, Japan
  • T. Ishikawa
    Ophthalmology, Tokyo medical University Hospital, Shinjuku, Japan
  • H. Hokama
    Ophthalmology, Tokyo medical University Hospital, Shinjuku, Japan
  • N. Yamakawa
    Ophthalmology, Tokyo medical University Hospital, Shinjuku, Japan
  • K. Ohi
    Ophthalmology, Tokyo medical University Hospital, Shinjuku, Japan
  • K. Kimura
    Ophthalmology, Tokyo medical University Hospital, Shinjuku, Japan
  • M. Usui
    Ophthalmology, Tokyo medical University Hospital, Shinjuku, Japan
  • Footnotes
    Commercial Relationships  Y. Katagiri, None; T. Iwasaki, None; T. Ishikawa, None; H. Hokama, None; N. Yamakawa, None; K. Ohi, None; K. Kimura, None; M. Usui, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3041. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Katagiri, T. Iwasaki, T. Ishikawa, H. Hokama, N. Yamakawa, K. Ohi, K. Kimura, M. Usui; Application of Thermo-setting Gel as Artificial Vitreous . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3041.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Intraocular gases and silicone oils are used as intraocular fillers in vitreoretinal surgery. They are all water repellent and are useful as intraocular tamponade. On the other hand, they are not suitable as vitreous substitute with added function as drug delivery system. We injected thermo-setting gel (TG), which has been developed to enhance the effect of glaucoma eye drops, into the vitreous cavity of domestic white rabbit and investigated the result. Methods:We used WTG-127 (Wakamoto Pharmaceutical Co. Ltd.), a TG with improved transparency, for intraocular injection.. After vitrectomy in a domestic white rabbit, we injected 2 ml of WTG-127 into the vitreous cavity. Slit-lump microscopy, indirect ophthalmoscopy, intraocular pressure (IOP) and electroretinogram (ERG) were conducted from 1 day to 1 month after the operation. Results:No corneal opacity, corneal edema, fibrin deposition in anterior chamber, lens opacity, vitreous opacity and rise of IOP were observed throughout the observation period. WTG-127 has good transparency, and did not interfere with fundal examination. No retinal abnormality was observed. ERG showed no reduced amplitude or prolonged latency in the postoperative eye compared with the untreated eye. Conclusions: WTG-127 maintains excellent transparency even after setting at body temperature, and no invasion to intraocular tissues was observed during the short observation period. This material has the potential of becoming a useful artificial vitreous with added function as a drug delivery system.

Keywords: vitreous substitutes • vitreoretinal surgery • animal model 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×